These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24282288)

  • 1. Secretory leukocyte protease inhibitor modulates urethane-induced lung carcinogenesis.
    Jan Treda C; Fukuhara T; Suzuki T; Nakamura A; Zaini J; Kikuchi T; Ebina M; Nukiwa T
    Carcinogenesis; 2014 Apr; 35(4):896-904. PubMed ID: 24282288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secretory leukocyte protease inhibitor inhibits expression of polymeric immunoglobulin receptor via the NF-κB signaling pathway.
    Mikami Y; Iwase T; Komiyama Y; Matsumoto N; Oki H; Komiyama K
    Mol Immunol; 2015 Oct; 67(2 Pt B):568-74. PubMed ID: 26239418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secretory leukocyte protease inhibitor promotes the tumorigenic and metastatic potential of cancer cells.
    Devoogdt N; Hassanzadeh Ghassabeh G; Zhang J; Brys L; De Baetselier P; Revets H
    Proc Natl Acad Sci U S A; 2003 May; 100(10):5778-82. PubMed ID: 12732717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal induction of secretory leukocyte protease inhibitor (SLPI) in odontoblasts by lipopolysaccharide and wound infection.
    Choi BD; Jeong SJ; Wang G; Kim HJ; Kim BO; Hwang HK; Lim DS; Kim SH; Jeong MJ
    J Endod; 2009 Jul; 35(7):997-1002. PubMed ID: 19567322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficiency of C-C chemokine receptor 5 suppresses tumor development via inactivation of NF-κB and inhibition of monocyte chemoattractant protein-1 in urethane-induced lung tumor model.
    Lee NJ; Choi DY; Song JK; Jung YY; Kim DH; Kim TM; Kim DJ; Kwon SM; Kim KB; Choi KE; Moon DC; Kim Y; Han SB; Hong JT
    Carcinogenesis; 2012 Dec; 33(12):2520-8. PubMed ID: 22907530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The alarm anti-protease, secretory leukocyte protease inhibitor, is a proliferation and survival factor for ovarian cancer cells.
    Simpkins FA; Devoogdt NM; Rasool N; Tchabo NE; Alejandro EU; Kamrava MM; Kohn EC
    Carcinogenesis; 2008 Mar; 29(3):466-72. PubMed ID: 17916899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretory leucoprotease inhibitor binds to NF-kappaB binding sites in monocytes and inhibits p65 binding.
    Taggart CC; Cryan SA; Weldon S; Gibbons A; Greene CM; Kelly E; Low TB; O'neill SJ; McElvaney NG
    J Exp Med; 2005 Dec; 202(12):1659-68. PubMed ID: 16352738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretory leukocyte protease inhibitor is associated with MMP-2 and MMP-9 to promote migration and invasion in SNU638 gastric cancer cells.
    Choi BD; Jeong SJ; Wang G; Park JJ; Lim DS; Kim BH; Cho YI; Kim CS; Jeong MJ
    Int J Mol Med; 2011 Oct; 28(4):527-34. PubMed ID: 21687932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory effects of mutant forms of secretory leukocyte protease inhibitor.
    Mulligan MS; Lentsch AB; Huber-Lang M; Guo RF; Sarma V; Wright CD; Ulich TR; Ward PA
    Am J Pathol; 2000 Mar; 156(3):1033-9. PubMed ID: 10702419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of NF-kappaB activation and augmentation of IkappaBbeta by secretory leukocyte protease inhibitor during lung inflammation.
    Lentsch AB; Jordan JA; Czermak BJ; Diehl KM; Younkin EM; Sarma V; Ward PA
    Am J Pathol; 1999 Jan; 154(1):239-47. PubMed ID: 9916938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretory leukocyte protease inhibitor regulates human periodontal ligament cell production of pro-inflammatory cytokines.
    Svensson D; Aidoukovitch A; Anders E; Jönsson D; Nebel D; Nilsson BO
    Inflamm Res; 2017 Sep; 66(9):823-831. PubMed ID: 28597116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The production of secretory leukocyte protease inhibitor by dendritic cells.
    Vroling AB; Konijn T; Samsom JN; Kraal G
    Mol Immunol; 2011 Jan; 48(4):630-6. PubMed ID: 21112636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of secretory leukocyte protease inhibitor on the production of some cytokines and nitric oxide by murine peritoneal macrophages in response to lipopolysaccharide stimulation and M. avium complex infection].
    Sano C; Shimizu T; Sato K; Ogasawara K; Tomioka H
    Kekkaku; 1999 Jul; 74(7):563-70. PubMed ID: 10481411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between secretory leukocyte protease inhibitor expression and Epstein-Barr virus status among patients with nasopharyngeal carcinoma.
    Tse KP; Wu CS; Hsueh C; Chang KP; Hao SP; Chang YS; Tsang NM
    Anticancer Res; 2012 Apr; 32(4):1299-307. PubMed ID: 22493362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori-induced downregulation of the secretory leukocyte protease inhibitor (SLPI) in gastric epithelial cell lines and its functional relevance for H. pylori-mediated diseases.
    Wex T; Treiber G; Venerito M; Leodolter A; Peitz U; Kuester D; Hritz I; Krueger S; Roessner A; Malfertheiner P
    Biol Chem; 2006 Jul; 387(7):893-901. PubMed ID: 16913839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of secretory leukocyte protease inhibitor as an inhibitor of implantation serine proteinases.
    Sharma N; Kaur J; Xu H; Zur Nieden N; Rancourt D
    Mol Reprod Dev; 2008 Jul; 75(7):1136-42. PubMed ID: 18163438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nrf2 prevents initiation but accelerates progression through the Kras signaling pathway during lung carcinogenesis.
    Satoh H; Moriguchi T; Takai J; Ebina M; Yamamoto M
    Cancer Res; 2013 Jul; 73(13):4158-68. PubMed ID: 23610445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The secretory leukocyte protease inhibitor (SLPI) suppresses cancer cell invasion but promotes blood-borne metastasis via an invasion-independent pathway.
    Sugino T; Yamaguchi T; Ogura G; Kusakabe T; Goodison S; Homma Y; Suzuki T
    J Pathol; 2007 Jun; 212(2):152-60. PubMed ID: 17455170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretory leukocyte protease inhibitor in cancer development.
    Devoogdt N; Revets H; Ghassabeh GH; De Baetselier P
    Ann N Y Acad Sci; 2004 Dec; 1028():380-9. PubMed ID: 15650263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of NF-κB by SOD2 promotes the aggressiveness of lung adenocarcinoma by modulating NKX2-1-mediated IKKβ expression.
    Chen PM; Wu TC; Wang YC; Cheng YW; Sheu GT; Chen CY; Lee H
    Carcinogenesis; 2013 Nov; 34(11):2655-63. PubMed ID: 23784082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.